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Abstract
Background: There is a need for improved targeting of antimalarial treatment if artemisinin
combination therapy is to be successfully introduced in Africa. This study aimed to explore why
malaria slides are requested and how their results guide treatment decisions in an area of low
transmission of P. falciparum.
Methods: Outpatients attending a district hospital in a highland area of Tanzania were studied over
a 3-week period. Clinical and social data were collected from patients who had been prescribed an
antimalarial or sent for a malaria slide. Hospital slides were re-read later by research methods.
Results: Of 1,273 consultations 132(10%) were treated presumptively for malaria and 214(17%)
were sent for a malaria slide; only 13(6%) of these were reported positive for P. falciparum but
96(48%) of the 201 slide-negative cases were treated for malaria anyway. In a logistic regression
model, adults (OR 3.86, P < 0.01), a history of fever (OR1.72, P = 0.03) and a longer travel time to
the clinic (OR 1.77 per hour travelled, P < 0.01) independently predicted the request for a malaria
slide. Only a history of a cough predicted (negatively) the prescription of an antimalarial with a
negative slide result (OR 0.44, P < 0.01). The sensitivity and specificity of hospital slide results were
50% and 96% respectively.
Conclusion: Progress in targeting of antimalarials in low malaria transmission settings is likely to
depend on consistent use of malaria microscopy and on the willingness of health workers to be
guided by negative slide results. Further studies are needed to identify how this can be achieved.
Background
In Tanzania, as in a number of African countries, existing
antimalarial treatment (sulphadoxine-pyrimethamine,
SP) is being replaced by artemesinin combination treat-
ment (ACT) as first line treatment for non-severe malaria.
However, at 5–10 times the cost of SP, its introduction
creates an urgent need to review the diagnostic and treat-
ment practices that have evolved over many years of cheap
and safe antimalarials [1-3].
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Where there is no access to microscopy presumptive diag-
nosis of malaria (fever with no obvious alternative cause)
is widely practiced and results in a large degree of unnec-
essary use of antimalarials, especially at low transmission
and in older children and adults in endemic areas [4].
Where available, microscopy offers a way forward but
there is evidence that it has little impact as health workers
frequently prescribe antimalarials in spite of a negative
result [5]. Anecdotal reports also suggest that many
patients are treated presumptively for malaria even when
microscopy is available and it is not clear if slides are
requested to confirm or exclude malaria or if patient
demand or ability to pay for the slide also influence the
decision to request a slide. There are few studies that have
addressed these questions especially in low transmission
settings in spite of the fact that approximately a third of
the population of Africa lives in such areas [6]. This study
was thus conducted in the outpatient clinic of a district
hospital in a low transmission area of Tanzania to under-
stand more about why a malaria slide is requested and
how the results guide treatment.
Methods
The study area
Njombe town (population 42,332) is situated in the
southern highlands of Tanzania at an altitude of between
1,800 and 1,920 metres and with a rainy season between
November and May. Economic activity in the area consists
of subsistence agriculture with some commercial farming
of pyrethrum and coffee.
The 'Malaria Assessment of Risk in Africa' initiative (using
projected rainfall and temperature) classifies the level of
P. falciparum transmission in the Njombe area as 'unstable
or absent' [7]. A survey of 100 consecutive children under
the age of 15 years who were waiting for a medical consul-
tation in Njombe Hospital in July 2004 found that only
4% were positive for P. falciparum [8].
Njombe District hospital serves the population of the
town and surrounding villages, most of which are served
by a dispensary without malaria microscopy. According to
routinely collected data in 2003 there were 53,546 outpa-
tient consultations, 19,812(37%) of which resulted in a
diagnosis of malaria; 10,165 blood slides were examined
in the hospital laboratory by 4 trained staff supported by
2 unqualified assistants. The mean number of slides/
working day/slide reader was 10.6(SD 2.0). Malaria slides
were charged at approximately $0.2 (U.S.) each for
patients over the age of 5 years.
Clinical and social data collection
All patients exiting from a medical out-patient consulta-
tion during a 3-week period and who had been prescribed
an antimalarial or who had a request for a malaria slide
were identified. Following consenting procedures, data
were collected on age, sex, village of residence, distance
and travel time to the clinic and the presence within the
previous 2 days of cough, fever, vomiting or diarrhoea,
'body pain', or any other symptom. Possible indicators of
socio-economic status were identified from local inter-
views and from opinions of researchers in Tanzania. Data
on 8 items (household possession of a car, motorbike,
bicycle, radio, mobile phone, television, fridge and any
bed net) were analysed for correlation; household posses-
sion of a bicycle or bed net were dropped due to poor cor-
relation and the remaining factors were found to highly
correlate (alpha = 0.77) and added to produce a socio-
economic score.
Patients were identified on exit from the review consulta-
tion and any changes to their medication were noted. Any
patient who appeared too ill to participate was referred
back to the clinic medical staff and not included in the
study.
Data were collected by locally recruited research assistants
who were not part of the normal hospital staff.
Laboratory data collection
Blood slide results were tracked at the end of each day and
the results were recorded from the laboratory results regis-
ter, although it was not possible to determine if there had
been an error in transcribing results to the register. Blood
slides in the hospital laboratory were stained with Giemsa
and 50 high power thick film fields were examined before
declaring a slide to be negative, with no system of report-
ing parasite densities. All clinic blood slides were marked
with the patient study number and retained for later
research-quality reading where the number of P. falci-
parum asexual parasites per 200 leucocytes was counted
on Giemsa-stained thick blood films. A slide was consid-
ered negative only after scanning 100 high power fields.
All slides were read twice independently with a third read-
ing if there was discordance, the majority result was
accepted as final.
Ethical approval and data management
Verbal consent of outpatient staff and written consent
from patients was obtained in all cases. Ethical approval
for the study was obtained from the review committees of
Kilimanjaro Christian Medical Centre, Tanzania and the
London School of Tropical Medicine and Hygiene.
Data were double-entered in Access (Microsoft Corpora-
tion, Redmond, WA) and statistical analysis was per-
formed using STATA 8 (Stata Corporation, College
Station, TX).Malaria Journal 2006, 5:4 http://www.malariajournal.com/content/5/1/4
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Results
Cases in the study, slide results and treatment given
During the 3-week period of the study there were there
were 1,273 outpatient attendances, 240(19%) of which
resulted in treatment for malaria. (Figure) Of the 346
patients who were recruited into the study approximately
half (160, 46%) were under the age of 15 years. Females
predominated in the 186 patients over the age of 15 years
(129, 69%).
A blood slide was requested for 214 patients and all of
these had a hospital laboratory slide result recorded. Thir-
teen (6%) of these were reported by the hospital labora-
tory as positive for P. falciparum asexual parasites and an
additional 35(16%) were reported as positive for P. falci-
parum  gametocytes. No other Plasmodium  species was
reported. Twelve (92%) of the cases reported as positive
for asexual parasites were treated with an antimalarial.
Thirty-three (94%) of the 35 patients with gametocytae-
mia reported by the hospital laboratory were also treated
with an antimalarial and all were reported as negative for
asexual parasites. Since gametocytes do not cause human
illness these cases have been classified as 'slide negative'.
The sensitivity and specificity of hospital slide results for
asexual parasitaemia (using the research slide result as the
reference) were 50% (95% CI 43–57) and 96% (95% CI
93–98) respectively, and positive and negative predictive
values were 31% (95% CI 26–37) and 98% (95% CI 96–
100) respectively. Five slides were judged to be unreada-
ble (all had been reported as negative by the hospital lab-
oratory). P. falciparum asexual parasite densities of the 8
positive research slide results were 2 at <2000/µl, 2 at
2000–4,999/µl, and 4 at >5,000/µl. The research slide
results identified only 3 positive slides for gametocytes, 2
of which were reported as negative by the hospital labora-
tory.
Factors associated with blood slide requests and treatment 
decisions
In a logistic regression model the request for a malaria
slide (as compared to presumptive treatment with no
slide request) was independently predicted by being aged
15 years or over (OR 3.86, P < 0.01), reporting a history of
fever in the previous 48 hours (OR 1.72, P = 0.03) and
reporting a longer travel time to the clinic (a 77% increase
in odds per hour travelled, P < 0.01). The request for a
malaria slide request was not significantly associated with
the socio-economic score (P = 0.26).(Table 2).
Of the 201 patients whose slide was reported as negative,
44(22%) were treated with an antimalarial only, 52(26%)
with an antimalarial and an antibiotic, 68 (34%) with an
antibiotic only, and 37(18%) with neither an antimalarial
nor an antibiotic. Thus overall, 96(48%) of patients
whose slide was reported as negative were treated with an
antimalarial and of these 29(30%) did not report a fever
within the previous 48 hours. Similarly, 47(36%) of those
treated presumptively for malaria also denied having a
fever within the previous 48 hours.
Table 2: Logistic regression model* of factors affecting the decision to request a malaria slide.
Antimalarial 
with no slide 
request 
(n = 132)
Slide request 
(n = 214)
Initial adjusted 
OR
PF i n a l  a d j u s t e d  
OR
P
Age 15 years or over, n (%) 47(36%) 139(65%) 4.03 <0.01 3.86 <0.01
Male (%) 58(44%) 78(37%) 1.01 0.16
Distance from village/km†: median (IQR)‡ 5(5–25) kms 10(5–25) kms 1.02 0.78
Hours to travel to clinic: median (IQR) 1(1–2) hrs 2(1–2) hrs 1.95 <0.01 1.77 <0.01
Socio-economic score§: mean 0.97 1.05 1.16 0.26
Number of days ill: median (IQR) 3(2–4) days 4(3–7) days 0.97 0.15
Antimalarial used in previous 48 hrs: n (%) 3(2.3%) 8(3.8%) 0.90 0.89
Fever in previous 48 hrs: n (%) 85(64%) 149(70%) 2.23 0.03 1.72 0.03
'Body pain' in previous 48 hrs: n (%) 92(70%) 168(79%) 1.06 0.84
Cough in previous 48 hrs: n (%) 71(54%) 97(46%) 0.93 0.79
Diarrhoea or vomiting in prev. 48 hrs: n (%) 55(43%) 82(38%) 0.87 0.60
Other symptom in previous 48 hrs: n (%) 33(25%) 46(22%) 0.66 0.18
*Logistic regression model with dependant variable = slide requested (1) or not requested (0), independent variables in model: aged 15 years or 
over, socio-economic score, distance to village, hours of travel to clinic, number of days ill, use of an antimalarial in 48 hrs before attendance, a 
report in the previous 48 hours of: fever, body pain, cough, diarrhoea or vomiting, or 'other' symptom (not specified). Variables were eliminated in 
a backwards fashion if p >= 0.1. All binary variables used the negative response as the baseline odds (i.e. OR = 1).
†Estimated distance between hospital outpatient clinic and village of residence.
‡IQR = Interquartile range
§Socio-economic score was derived from principal components analysis of reported possession in the household of the following: car, motorbike, 
radio, mobile phone, television, or refrigerator.Malaria Journal 2006, 5:4 http://www.malariajournal.com/content/5/1/4
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A logistic regression model using the same factors listed in
Table 2 was used to test for an association with prescribing
(compared to not prescribing) antimalarial treatment
where the hospital slide result was reported as negative;
the only factor found to be independently predictive was
a negative association with a history of cough within the
previous 48 hrs (OR 0.44, P < 0.01). Using the same vari-
ables to test the odds of being prescribed an antimalarial
irrespective of whether a malaria slide was requested, only
being under the age of 15 years was independently predic-
tive (OR 2.25, p < 0.01).
Discussion
In this study almost 20% of all outpatients were diag-
nosed and treated for malaria and routine data reported
this proportion as almost 40% in the previous year, sug-
gesting a possible moderating influence of the study itself.
Blood slides were not collected from presumptively
treated cases for fear of influencing clinical practice, but
even if twice as many of these were positive compared to
those who were sent for a malaria slide, well over 90% of
treated cases did not have malaria, a finding consistent
with other studies [4,9]. Hay et al. have estimated that
over a third of the population of malaria-endemic coun-
tries in Africa lives under low or epidemic-prone transmis-
sion levels of malaria[6] and, although there are
insufficient data to make a detailed extrapolation, it seems
likely that a substantial proportion of avoidable antima-
larial treatments in Africa is dispensed in these settings.
Health workers demonstrated unrealistic confidence in
their ability to make a clinical diagnosis of malaria. Thus,
as would be reasonable in a high transmission area, chil-
dren tended to be treated presumptively. The failure to
request a blood slide did not seem to be justified by exces-
sive workload (although it is likely to be a factor in many
settings) and data were not collected on the influence of
waiting times on the request for a slide. However, if a
blood slide is requested it is logical to expect the result to
guide treatment decisions but almost half of those with a
Cases in the study by malaria slide result and treatment given Figure 1
Cases in the study by malaria slide result and treatment given.
Treated for malaria or sent for a
malaria slide
346 (27%)
Malaria slide requested
214 (62%)
Slide pos. 13 (6%)
(Research slide pos: 4)
Slide neg. 201 (94%)
(Research slide pos.: 4)
Antimalarial prescribed
12 (92%)
Antimalarial prescribed
96 (48%)
1274 outpatient attendances
Presumptive treatment for malaria
132 (38%)Malaria Journal 2006, 5:4 http://www.malariajournal.com/content/5/1/4
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negative result were treated with an antimalarial anyway.
If the clinical suspicion of malaria is strong then this
might override the slide result (although logically one
could ask why request a slide at all?) but 30% of slide-neg-
ative cases treated for malaria did not report a recent his-
tory of a fever. When requested, it was not clear if slide
results were being used to confirm or exclude malaria;
while children were almost 4 times less likely than adults
to be slide-tested, those sent for a slide were more likely to
have reported a recent history of fever than those treated
presumptively.
Our results suggest that malaria slides in clinics may fulfil
a social or ritual function. In this study, a slide request was
more likely if patients had travelled further (suggesting
patient motivation to attend a facility where microscopy
was available) although there was no association with
socio-economic status suggesting that the cost of the slide
does not play a major role. Clearly, for health workers,
malaria is a convenient and acceptable label for non-spe-
cific illness but little is known about the understanding of
malaria that leads to such practice and whether the phe-
nomenon is driven more by patients or health workers.
Presumptive diagnosis of malaria is an effective strategy to
increase coverage of antimalarials in high transmission
areas where malaria is common, the risk of progression to
severe malaria is significant, and diagnostic facilities are
lacking. In low transmission areas the justification for pre-
sumptive diagnosis is much less clear. Current Malaria
Guidelines in Tanzania[10] do not vary by transmission
intensity (although the most recent version does distin-
guish between those over and under the age of 5 years)
but the introduction of ACTs creates a strong economic
case that in low transmission areas treatment for malaria
should, wherever possible, be restricted to parasitologi-
cally proven cases [1]. Such an approach will have addi-
tional benefits in that patients are more likely to be treated
for the actual cause of their illness and generation of more
reliable routine data can support improved health plan-
ning as well as give early warning of epidemics. How to
achieve a situation where health workers respect negative
slide results is unclear; in a teaching hospital it has been
possible in patients over the age of 5 years[11] but, as far
as we are aware, there are no similar reports in less super-
vised settings where the majority of patients are seen.
While clear national guidelines, improved laboratory
standards and RDTs all have a role, it is optimistic to
expect these to have a major impact without addressing
prescribing behaviour and patient expectations about
which there is currently little in-depth knowledge.
The accuracy of slide reading in this study was low
although the negative predictive value (being dependent
on prevalence) was still in excess of 95%, providing a high
likelihood that a decision to withhold an antimalarial on
the basis of a negative slide would be correct. In spite of
this there is clearly an urgent need to improve laboratory
standards; Bates et al.[12] have shown that this can be
achieved with a relatively simple system of quality control
and further improvements are likely if laboratory staff
more frequently see that their results actually influence
clinical decisions.
Conclusion
Reducing the overuse of antimalarials is an important and
complex challenge. The criteria that are used to request a
malaria slide are inconsistent and, where requested, nega-
tive results are often disregarded. If RDTs are introduced
on a wide scale in Africa similar questions regarding con-
sistent use, quality control and use of the results will need
to be addressed.
Authors' contributions
HR and CD conceived of the study and its design and
drafted the manuscript. JR coordinated the data collection
and OM analysed the data; both JR and OM made critical
comments to the manuscript.
Table 1: Total outpatient attendances during the 21-day period of the study according to primary diagnosis.
Diagnosis *Age <5 yr Age 5+ yr Total
Acute respiratory infection 184(40%) 174(21%) 358(28%)
Malaria 96(21%) 144(18%) 240(19%)
Diarrhoea 58(13%) 59(7%) 117(9%)
Skin infection 23(5%) 21(3%) 44(3%)
Intestinal helminths 17(4%) 9(1%) 26(2%)
Ear infection 7(2%) 7(1%) 14(1%)
Urinary tract infection 3(1%) 11(1%) 14(1%)
Anaemia 2(0.4%) 10(1%) 12(1%)
Other 70(15%) 378(46%) 448(35%)
Total 460 813 1,273
*Age groups determined by routine reporting of outpatient attendances according to Ministry of Health guidelines.Publish with BioMed Central    and   every 
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